Clinical trial
Entecavir Plus Adefovir Combination Therapy Versus Entecavir Monotherapy vs…
NCT00410202 · Bristol-Myers Squibb, Industry · Completed
Key facts
| NCT number | NCT00410202 |
|---|---|
| Title | Entecavir Plus Adefovir Combination Therapy Versus Entecavir Monotherapy vs Therapy With Adefovir Plus Lamivudine for Chronic Hepatitis B Infected Subjects With Lamivudine-resistant Virus |
| Official title | A Comparative Study of Entecavir vs. Adefovir Plus Lamivudine vs Combination Entecavir Plus Adefovir in Lamivudine-resistant Chronic Hepatitis B Subjects: The DEFINE Study |
| Acronym | DEFINE |
| Lead sponsor | Bristol-Myers Squibb, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hepatitis B, Chronic |
| Intervention type | Drug |
| Interventions | Entecavir, Tenofovir, Adefovir, Lamivudine |
| Enrollment | 629 |
| Start date | Mar 1, 2008 |
| Primary completion | Jan 1, 2011 |
| Completion | Jul 1, 2012 |
| First posted | Dec 12, 2006 |
| Last update posted | Nov 21, 2013 |
| Countries | Australia, Brazil, Canada, Greece, Hong Kong, India, Indonesia, Italy, Malaysia, Philippines, Poland, Russia and 6 more |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: